The Food and Drug Administration is pushing to approve Pfizer-BioNTech’s two-dose Covid-19 vaccine on Monday, further expediting an earlier timeline for licensing the shot, according to people familiar with the agency’s planning.

An F.D.A. spokeswoman declined to comment.

The agency had recently set an unofficial deadline for approval of around Labor Day.

READ FULL ARTICLE HERE AT THE NEW YORK TIMES:
nytimes.com/2021/08/20/us/politics/fda-pfizer-covid-vaccine-full-approval.html

Other Headlines

Coronavirus

NEBRASKA AG: Docs Can Prescribe Ivermectin, Hydroxychloroquine

Nebraska’s attorney general says he won’t seek disciplinary action against doctors who prescribe off-label drugs to treat and prevent coronavirus infections, as long as they get informed consent from patients and don’t engage in misconduct. The office of Attorney General Doug Peterson released a legal opinion saying it didn’t see data to justify legal action against healthContinue reading NEBRASKA AG: Docs Can Prescribe Ivermectin, Hydroxychloroquine

More news about Coronavirus